樂觀
$0.73
情境價格
$2.090
+0.105 (+5.03%)收盤時
So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website.
So-Young International Inc is not a good buy right now due to its current price of 1.99, which is significantly below its 52-week high of 4.75, and an RSI of 12.45 indicating it is oversold. While the company has shown revenue growth, with Q2 2026 revenue at 505.2 million CNY, a 33% year-over-year increase, it still faces significant net losses, with a net income of -22.7 million CNY in Q2 2026. The main risk is its negative earnings per share of -0.29, which reflects ongoing financial challenges despite some positive revenue trends.
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

So-Young International Reports Record Q2 Revenue Growth

So-Young International Reports Strong Q2 2026 Financial Results

So-Young International Reports Strong Q2 2026 Financial Results

So-Young International to Report Q2 2026 Financial Results

So-Young International Appoints New CFO
So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website. It operates in the Consumer Cyclicals sector (COMPUTER PROCESSING AND DATA PREPARATION AND PROCE industry).
So-Young International Inc is not a good buy right now due to its current price of 1.99, which is significantly below its 52-week high of 4.75, and an RSI of 12.45 indicating it is oversold. While the company has shown revenue growth, with Q2 2026 revenue at 505.2 million CNY, a 33% year-over-year increase, it still faces significant net losses, with a net income of -22.7 million CNY in Q2 2026. The main risk is its negative earnings per share of -0.29, which reflects ongoing financial challenges despite some positive revenue trends.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。